Second cancers following antineoplastic therapy (Q39820178)

14 September 2017

1 reference

title

Second cancers following antineoplastic therapy (English)

1 reference

14 September 2017

Dorr FA

1

1 reference

14 September 2017

Coltman CA Jr

series ordinal

2

1 reference

14 September 2017

publication date

1 February 1985

1 reference

Current Problems in Cancer

14 September 2017

published in

1 reference

14 September 2017

volume

9

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

1-43

1 reference

Multiple primary malignant neoplasms.Historical perspectives

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Occurrence of malignancy in immunodeficiency diseases. A literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Primary lymphoma of the nervous system associated with acquired immune-deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Carcinogenic action of anticancer drugs with special reference to immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan. II. Pathologic study and supplementary epidemiologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Cancer mortality among patients with ankylosing spondylitis not given X-ray therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Radiation hazards: 25 years of collaborative research. Sylvanus Thompson memorial lecture, April 1980.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Mortality and Cancer Frequency Among Military Nuclear Test (Smoky) Participants, 1957 Through 1979

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

An estimate of the radiation-induced cancer risk from the whole-body stray radiation exposure in neutron radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

The contribution of ionizing radiation to cancer mortality in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Leukemia and other cancers following radiation treatment of pelvic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

The carcinogenicity of anticancer drugs: a hazard in man

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Temporal aspects of occupational bladder carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

The origin of human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Cancer in connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Sjögren's syndrome: an update and overview

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Occurrence of second tumors in man after anticancer drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Report of the committee on chromosome rearrangements in neoplasia and on fragile sites

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Chromosomes and causation of human cancer and leukemia. L. Cytogenetics of leukemias complicating other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute myeloid leukemia following treatment of Hodgkin's disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Therapy-related leukemia. A panmyelosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Therapy of secondary acute nonlymphocytic leukemia with cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute nonlymphocytic leukemia after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Second malignancies complicating Hodgkin's disease in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Hematologic neoplasia in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Second malignancies in Hodgkin's disease: a complication of certain forms of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Secondary Leukemia Following Treatment of Hodgkin’s Disease: Ultrastructural and Cytogenetic Data in Two Cases with a Review of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Second malignancy in patients treated by Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Risk of leukemia in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute Leukemia in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Breast cancer and acute leukemia: Report of 24 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

1 reference

7 January 2021

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute leukemia after chemotherapy (melphalan)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Second malignancies in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Acute nonlymphocytic leukemia and acute myeloproliferative syndrome following radiation therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia: Clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Residual marrow injury following cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Second Lymphoid Malignant Neoplasms Occurring in Patients Treated for Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Non-Hodgkin's lymphoma occurring after hodgkin's disease four new cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Second Primary Neoplasms Following Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Risk of new cancers in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Solid Tumors in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

The Incidence Of Bladder Cancer after Cyclophosphamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Bladder cancer following administration of cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Does cyclophosphamide induce bladder cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Risk factors for thyroid abnormalities after neck irradiation for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Sarcoma arising in irradiated bone; report of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Radiation-induced sarcoma of bone: Clinical and radiographic findings in 43 patients irradiated for soft tissue neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

Pleomorphic liposarcoma following radiotherapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

The Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2885%2980033-7

7 January 2021

10.1016/S0147-0272(85)80033-7

Identifiers

DOI

1 reference

14 September 2017

1 reference